Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes-Reference-Cited by-同舟云学术

Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes

Published:2021-03 Issue:1 Volume:35 Page:101657
ISSN:1521-6942
Container-title:Best Practice & Research Clinical Rheumatology
language:en
Short-container-title:Best Practice & Research Clinical Rheumatology

Author:

Grainger Rebecca,Machado Pedro M.,Robinson Philip C.

Funder

Pfizer Australia

Cornerstones

Janssen New Zealand

Janssen Australia

Novartis

Abbvie

BMS

Celgene

Eli Lilly

Janssen

MSD

Orphazyme

Pfizer

Roche

UCB

Gilead

National Institute for Health Research

University College London Hospitals

Biomedical Research Centre

Publisher

Elsevier BV

Subject

Rheumatology

Reference50 articles.

1. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses;Zhu;Respir Res,2020

2. Antirheumatic disease therapies for the treatment of COVID-19: a systematic review and meta-analysis;Putman;Arthritis Rheum,2020

3. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis;Akiyama;Annals of the Rheumatic Diseases annrheumdis–,2020

4. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs;Michelena;Semin Arthritis Rheum,2020

5. COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study;Zhong;Lancet Rheumatol,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study;Frontiers in Pharmacology;2023-12-06

2. Accessing care during the pandemic: A UK wide survey of people with rheumatoid arthritis and adult juvenile inflammatory arthritis during the COVID‐19 pandemic;Musculoskeletal Care;2023-05-09

3. Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders;European Journal of Pediatrics;2023-04-19

4. CLINICAL COMPARISON OFEFFICACY BETWEEN COMBINATIVE THERAPIES IN MANAGEMENT OF SARS-COV-2-INDUCED ARTHRITIS: NSAIDS AND STEROIDS VERSES NSAIDS AND CHONDROPROTECTIVE AGENTS;Grail of Science;2023-03-31

5. Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective;Clinical Rheumatology;2023-01-13